Recruiting
Testing of Bevacizumab, Erlotinib, and Atezolizumab in Combination for Advanced-Stage Kidney Cancer
NCT04981509
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +21 more
- Locations
-
- UC San Diego Moores Cancer Center La Jolla, California, United States
- Emory University Hospital Midtown Atlanta, Georgia, United States
- Emory University Hospital/Winship Cancer Institute Atlanta, Georgia, United States
- Emory Saint Joseph's Hospital Atlanta, Georgia, United States